What To Expect On Tomorrow's Market 明天市场会怎样走

Pacific Time 8:18 PM, Dow Jones Industrial Average futures were up 821 points, or about 3.51%. S&P 500 futures gained 87 or 3.12% while Nasdaq 100 futures were up by 181 or 2.07%. Gilead (GILD) jumped by 16.41% in after-hours trading. Boeing (BA) stock jumped nearly 9% in after hour trading.  See below for news details. Both the Gilead and Boeing news are helping stock future surging. President Donald Trump’s guidelines that revealed a three-phase plan that could allow some states to begin as early as this month lifting limits meant to contain the disease’s spread also boosting sentiment. However, among the 3 news mentioned above, only the Boeing news is solid and may provide support to the market since it's a Dow component. The Trump news is only a guideline, when to lift restriction is still to be seen. As far as the Gilead news is concern it is just fake news meant to pump up Gilead stock. So beware that tomorrow's initial market surge may be met by selling. I would think traders might use the opportunity to sell after the recent sharp rise before the weekend.  Index futures indicate the levels that the major indexes may be challenged are S&P 500 2900, Dow 24660 and Nasdaq Composite 9000.  Assuming the Nasdaq Composite reaches 9000 tomorrow, it would only be down 8.5% from all time high. It would really be absurd to have the market down only this little as the economy is entering a recession (may be depression) and the future is still uncertain. That's why I believe the levels mentioned above for Dow, S&P 500 and Nasdaq composite are resistances and would invite selling.

。A report from health-care media site Stat indicated promising results from therapeutics used to treat the novel strain of coronavirus. The report indicated that 125 COVID-19 patients in a study were discharged after treatment with Gilead's remdesivir. However, the results represent a very small sample and don't qualify as clinical data. Still investors appeared heartened by the report as the deadly pathogen has claimed 140,000 lives and infected more than 2 million people globally, shutting down large swaths of economies world-wide. ---Market Watch

。Gilead issued a statement which suggested that STAT was pumping the stock based on nothing more than "anecdotal reports" :

"We understand the urgent need for a Covid-19 treatment and the resulting interest in data on our investigational antiviral drug remdesivir. The totality of the data need to be analysed in order to draw any conclusions from the trial." "Anecdotal reports, while encouraging, do not provide the statistical power necessary to determine the safety and efficacy profile of remdesivir as a treatment for Covid-19. We expect the data from our Phase 3 study in patients with severe Covid-19 infection to be available at the end of this month, and additional data from other studies to become available in May." ---Zero Hedge

。Boeing (NYSE:BA) +8.75% after-hours as it announces plans to resume production of all commercial airplanes in a phased approach at its Seattle-area facilities next week. The company says ~27K employees in the Puget Sound area will return to production of the 747, 767, 777 and 787 programs, and the 737 program will resume working toward restarting production of the 737 MAX.---Seeking Alpha




太平洋时间晚上8:18 ,道琼斯工业平均指数期货上涨821点，或约3.51％。 标普500期货上涨87或3.12％，纳斯达克100期货上涨181或2.07％。 吉利德（GILD）在盘后交易中上涨了14％。 波音（BA）股价在盘后交易中上涨了近9％。 请参阅下面的新闻详细信息。 吉利德（Gilead）和波音（Boeing）的消息都在帮助股市上涨。 唐纳德·特朗普总统透露了一个分三个阶段的开放准则，该准则允许某些州最早在本月开始实施放宽旨在遏制病毒蔓延的限制，这也提振了市场情绪。 但是，在上述三则新闻中，只有波音新闻是可靠的，并且由于它是道琼斯指数的成分股，因此可能为市场提供支撑。 特朗普的新闻只是一个开放准则，何时解除限制还有待观察。 就吉利德新闻而言，这只是“假消息”，意在推高吉利德的股票。 因此要注意，明早市场的大升很可能会带来抛售。 炒家很可能会利用这个机会在周末之前卖股, 尤其是经过近期的大升后。 由于指数期货显示标准普尔500 2900，道琼斯指数24660和纳斯达克综合指数9000是可能受到挑战的水平。假设纳斯达克综合指数达到9000点水平，那将仅从历史高点下跌8.5％。 当经济正进入衰退（可能是萧条）并且未来仍不确定时，股市跌这么小是极其荒谬的。所以上面提到的道指，标普500 及纳指水平就是阻力水平而将招来抛售。

。卫生保健媒体网站Stat 的一份报告指出，用于治疗这种新型冠状病毒的疗法的疗效令人鼓舞。 该报告表明，在一项研究中，有125名COVID-19患者在接受吉利德的瑞姆昔韦 ( Gilead 的remdesivir）治疗后出院。 但是，结果仅代表很小的样本，不能作为临床数据。 这份报告仍然使投资者感到鼓舞，因为致命的病原体在全球夺走了14万条生命，并感染了超过200万人，从而关闭了世界范围内的大部分经济体。---Market Watch

。吉利德（Gilead）发表声明，暗示STAT只是根据“轶事报告”来推高股票：
“我们了解迫切需要Covid-19治疗，以及由此产生的对我们研究用抗病毒药物瑞姆昔韦的数据的兴趣。需要对数据的整体进行分析，以便从试验中得出任何结论。” “尽管有令人鼓舞的传闻，但并未提供必要的统计能力来确定雷姆昔韦治疗Covid-19的安全性和疗效概况。我们预计，来自重度Covid-19感染患者的第3期研究数据将于本月底提供，其他研究的数据将于5月份提供。”

。波音（BA）盘后上涨8.75％，该公司宣布计划下周在西雅图地区的工厂分阶段恢复所有商用飞机的生产。 该公司表示，普吉特海湾地区约27,000名员工将恢复生产747、767、777和787程序，而737程序将继续致力于恢复737 MAX的生产。---Seeking Alpha